Paclitaxel is an ICD inducer whose activity is characterized by the release of HMGB1 in osteosarcoma cells (58) and upregulation of CALR in lung cancer cells (Table 1) (Figure 3) (59). This evidence concerns the gene HMGB1 and lung carcinoma.